PAPER Radin DP, Zhong S, Cerne R, Shoaib M, Smith JL, Witkin J, Lippa A

Preclinical Pharmacology of CX1837, a High-Impact Ampakine with an Improved Safety Margin: Implications for Treating Alzheimer's Disease and Ischemic Stroke.

Curr Alzheimer Res. 2025 Feb 10; Epub 2025 Feb 10 PubMed.

PAPER Mumtaz, Ahmed F, Rabbani SA, El-Tanani M, Najmi AK, Ali J, Khan MA

Tauopathy in AD: Therapeutic Potential of MARK-4.

Curr Alzheimer Res. 2025 Feb 10; Epub 2025 Feb 10 PubMed.

PAPER Cho Y, Lee J, Kim JS, Jeon Y, Han S, Cho H, Lee Y, Kim TK, Hong JM, Lee Y, Byun Y, Chae M, Park S, Palomera LF, Park SY, Kim H, Kim S, Kang S, Jee JG, An H, Yim JH, Kim SH, Jo DG

RA-PR058, a novel ramalin derivative, reduces BACE1 expression and phosphorylation of tau in Alzheimer's disease mouse models.

Anim Cells Syst (Seoul). 2025;29(1):122-134. Epub 2025 Feb 7 PubMed.

PAPER Ding J, Long Z, Liu Y, Wang M

Study on influencing factors of age-adjusted Charlson comorbidity index in patients with Alzheimer's disease based on machine learning model.

Front Med (Lausanne). 2025;12:1497662. Epub 2025 Jan 27 PubMed.

PAPER Silva-Llanes I, Madruga E, Martínez A, Lastres-Becker I

RIPK1 expression and inhibition in tauopathies: implications for neuroinflammation and neuroprotection.

Front Neurosci. 2024;18:1530809. Epub 2025 Jan 27 PubMed.

PAPER Engelhardt E, Grinberg LT

The underappreciated contribution of Oskar Fischer to the knowledge of Frontotemporal Lobar Degeneration.

Dement Neuropsychol. 2025;19:e20240226. Epub 2025 Feb 10 PubMed.

PAPER Nevzorova KV, Shpilyukova YA, Fedotova EY, Burmak AG, Shabalina AA, Illarioshkin SN

[The experience of diagnosing Alzheimer's disease based on the study of cerebrospinal fluid biomarkers].

Zh Nevrol Psikhiatr Im S S Korsakova. 2025;125(1):91-97. PubMed.

PAPER Gravitz L

Gains in early-onset dementia with progranulin open new paths for drug discovery.

Nat Biotechnol. 2025 Feb;43(2):151-153. PubMed.

PAPER Balakrishnan NB, Pillai AS, Jose Panackal J, Sreeja PS

Alzheimer's Disease detection and classification using optimized neural network.

Comput Biol Med. 2025 Mar;187:109810. Epub 2025 Feb 11 PubMed.

PAPER Ullah K, Almutairi MH, Abbas MN, Wahab A, Nayab S, Fozia F, Khan MA, Shah ZA, Ahmad I, Almutairi BO, Ziaullah Z

Discovery of Selective β-Secretase (BACE-1) Inhibitors by the Solid-Phase Synthesis of Small Molecular-sized Peptides.

Curr Alzheimer Res. 2025 Feb 10; Epub 2025 Feb 10 PubMed.

PAPER Li H, Qiao Z, Xiao X, Cao X, Li Z, Liu M, Jiao Q, Chen X, Du X, Jiang H

G protein-coupled receptors: A golden key to the treasure-trove of neurodegenerative diseases.

Clin Nutr. 2025 Mar;46:155-168. Epub 2025 Feb 2 PubMed.

PAPER Alqahtani T, Khandia R, Puranik N, Alqahtani AM, Alghazwani Y, Alshehri SA, Chidambaram K, Kamal MA

Corrigendum: Codon usage is influenced by compositional constraints in genes associated with dementia.

Front Genet. 2025;16:1556255. Epub 2025 Jan 27 PubMed. Corrected paper.

PAPER Böken D, Xia Z, Lam JY, Fertan E, Wu Y, English EA, Konc J, Layburn F, Bernardes GJ, Zetterberg H, Cheetham MR, Klenerman D

Correction to "Ultrasensitive Protein Aggregate Quantification Assays for Neurodegenerative Diseases on the Simoa Platform".

Anal Chem. 2025 Feb 25;97(7):4251. Epub 2025 Feb 10 PubMed. Corrected paper.

PAPER Kong D, Meng L, Lin P, Wu G

Advancements in PROTAC-based therapies for neurodegenerative diseases.

Future Med Chem. 2025 Mar;17(5):591-605. Epub 2025 Feb 11 PubMed.

PAPER Seo JY, Kim J, Ko YH, Lee BR, Hur KH, Jung YH, Park HJ, Lee SY, Jang CG

A Novel Histone Deacetylase 6 Inhibitor, 4-FHA, Improves Scopolamine-Induced Cognitive and Memory Impairment in Mice.

Biomol Ther (Seoul). 2025 Mar 1;33(2):268-277. Epub 2025 Feb 12 PubMed.